Science Explorer Back to mapMap
Discussion
Researcher · Seoul National University Hospital · South Korea

Seock‐Ah Im

Seock‐Ah Im publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research and Breast Cancer Treatment Studies.

ORCID 0000-0002-5396-6533 OpenAlex
World rank
#50,255
of 7,710,434 ranked researchers
Rank in South Korea
#198
of 162,609
Works
1,172
Citations
73k
Citations per work
62.4
h-index
101
i10-index 528Top 0.3% in Oncology
Seock‐Ah Im

What does Seock‐Ah Im research?

Seock‐Ah Im's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (18%).

Health Sciences: 717 works · 61.2% of their workMedicine: 717 works · 61.2% of their workOncology: 402 works · 34.3% of their workPulmonary and Respiratory Medicine: 217 works · 18.5% of their workSurgery: 52 works · 4.4% of their workRadiology, Nuclear Medicine and Imaging: 47 works · 4.0% of their workEverything else: 238 works · 20.3% of their workLife Sciences: 217 works · 18.5% of their workBiochemistry, Genetics and Molecular Biology: 217 works · 18.5% of their workCancer Research: 134 works · 11.4% of their workMolecular Biology: 83 works · 7.1% of their workTHEIR WORKSeock‐Ah Im1,172works
Life Sciences18%Health Sciences61%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine71761.2%
  2. Everything else23820.3%
    1. Biochemistry, Genetics and Molecular Biology21718.5%
  1. 1Oncology34% of their works
  2. 2Pulmonary and Respiratory Medicine18% of their works
  3. 3Cancer Research11% of their works
  4. 4Molecular Biology7% of their works
  5. 5Surgery4% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Seock‐Ah Im's research?

The keywords of their largest research topics: Breast Cancer, Metastatic Breast Cancer, Chemotherapy, Clinical Practice Guidelines, Survival Analysis, Molecular Subtypes, CDK4/6 Inhibitors and Palbociclib.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Breast Cancer5242 topics
  2. Metastatic Breast Cancer4452 topics
  3. Chemotherapy3723 topics
  4. Clinical Practice Guidelines3002 topics
  5. Survival Analysis3002 topics
  6. Molecular Subtypes2992 topics
  7. CDK4/6 Inhibitors2811 topic
  8. Palbociclib2811 topic
  9. HER22431 topic
  10. Trastuzumab2431 topic
  11. Breast Tumours2351 topic
  12. Gene Expression2351 topic
  13. Chemotherapy-Induced Peripheral Neuropathy1641 topic
  14. Taxanes1641 topic
  15. Immune Checkpoint Blockade791 topic
  16. PD-1 and PD-L1791 topic
  17. BRCA Mutation741 topic
  18. PARP Inhibitors741 topic
  19. Endoscopic Resection651 topic
  20. Gastric Cancer651 topic
  21. Cetuximab641 topic
  22. KRAS Mutations641 topic

Where does Seock‐Ah Im work?

Seock‐Ah Im's main affiliation in the publication record is Seoul National University Hospital, South Korea.

How many publications and citations does Seock‐Ah Im have?

OpenAlex counts 1,172 works and 73,082 citations for Seock‐Ah Im, an h-index of 101, ranking #50,255 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Seock‐Ah Im

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Seock‐Ah Im. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.